Carson Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.45M Sell
10,022
-142
-1% -$33.1K 1.27% 19
2025
Q4
$2.1M Sell
10,164
-527
-5% -$104K 1.09% 19
2025
Q3
$1.98M Buy
10,691
+8
+0.1% +$1.37K 1.07% 19
2025
Q2
$1.63M Sell
10,683
-4
-0% -$615 1.04% 23
2025
Q1
$1.77M Sell
10,687
-118
-1% -$18.5K 1.19% 21
2024
Q4
$1.56M Sell
10,805
-146
-1% -$22.6K 1.09% 23
2024
Q3
$1.77M Sell
10,951
-406
-4% -$64.7K 1.11% 21
2024
Q2
$1.66M Buy
11,357
+1,215
+12% +$181K 1.16% 23
2024
Q1
$1.6M Buy
10,142
+167
+2% +$26.6K 1.13% 21
2023
Q4
$1.56M Sell
9,975
-241
-2% -$37K 1.22% 20
2023
Q3
$1.59M Sell
10,216
-318
-3% -$52.5K 1.39% 14
2023
Q2
$1.74M Sell
10,534
-178
-2% -$28.7K 1.47% 12
2023
Q1
$1.66M Buy
10,712
+600
+6% +$96.9K 1.48% 13
2022
Q4
$1.79M Buy
10,112
+606
+6% +$105K 1.71% 15
2022
Q3
$1.55M Buy
9,506
+1,268
+15% +$215K 1.72% 15
2022
Q2
$1.46M Sell
8,238
-223
-3% -$39.7K 1.63% 15
2022
Q1
$1.5M Buy
8,461
+37
+0.4% +$6.3K 1.49% 15
2021
Q4
$1.44M Buy
+8,424
New +$1.38M 1.46% 15

Other funds holding JNJ

Carson Advisory's JNJ Position: Q1 2026 in Review

Carson Advisory reduced its Johnson & Johnson (JNJ) stake by 1.4% in Q1 2026, selling an estimated $33.1K and leaving 10,022 shares worth $2.45M. The position accounts for 1.27% of the portfolio, ranked #19.

Carson Advisory first reported a position in JNJ in Q4 2021 and has held it in 18 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Carson Advisory held 10,022 shares of Johnson & Johnson worth $2.45M as of Q1 2026.
  • Carson Advisory sold 142 Johnson & Johnson shares in Q1 2026, an estimated $33.1K.
  • Johnson & Johnson made up 1.27% of Carson Advisory's portfolio in Q1 2026, its #19 holding.
  • Carson Advisory first reported a position in Johnson & Johnson in Q4 2021 and has held it in 18 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Carson Advisory's 13F filing for Q1 2026, filed 7 May 2026.